Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.
about
Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@ast
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@en
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@nl
type
label
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@ast
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@en
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@nl
prefLabel
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@ast
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@en
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@nl
P2093
P2860
P1476
Phase I trial of radiotherapy ...... improve the therapeutic ratio.
@en
P2093
Aron Popovtzer
Avraham Eisbruch
Carol R Bradford
Francis P Worden
Gregory T Wolf
Mark E Prince
Theodore S Lawrence
P2860
P304
P356
10.1016/J.TRANON.2014.04.016
P577
2014-08-01T00:00:00Z